Literature DB >> 583074

The clinical features and HLA associations of reactive arthritis associated with non-gonococcal urethritis.

A C Keat, R N Maini, G D Pegrum, J T Scott.   

Abstract

Fifty-seven patients with arthritis associated with non-gonococcal genital infection have been studied. Synovitis characteristically affected one or a few joints, expecially the knee, ankle or metatarsophalangeal joints and was accompanied by tenosynovitis and enthesopathies--each in about one third of the patients. A quarter of the patients had ocular, cutaneous, or mucous membrane lesions (Reiter's syndrome). Although six patients developed a chronic or relapsing course, average duration of the acute episode in the majority was three to five months. Available evidence strongly suggests that infection following sexual intercourse, usually but not always with a new partner, was instrumental in the initiation of the disease. We have suggested the term 'sexually acquired reactive arthritis (SARA)' to emphasize the mode of acquisition of the disease, and note that similar syndromes are seen associated with gut infection. We consider that usage of the term Reiter's syndrome is correctly applied to only those cases which exhibited the characteristic triad of urethritis, arthritis and conjunctivitis with or without other cutaneous and mucous membrane lesions. Thirty-six of the 54 patients who were HLA typed (67 per cent) possessed the antigen HLA-B27. Of 30 who presented directly to a rheumatology unit 25 (82 per cent) were HLA-B27 positive. The other 24 patients initially attended a venereology clinic and only 11 (46 per cent) of these bore the antigen. This appears to reflect disease severity, HLA-B27 positive patients having a significantly longer duration of disease symptoms and a higher frequency of extra-articular manifestations, than those lacking this antigen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583074

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  15 in total

1.  In defence of eponyms.

Authors:  V Wright
Journal:  BMJ       Date:  1991 Dec 21-28

2.  Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.

Authors:  C T Pease; M Fennell; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

3.  Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease.

Authors:  A Ratcliffe; M Doherty; R N Maini; T E Hardingham
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

4.  Incomplete Reiter's syndrome following chemotherapy of acute myeloid leukaemia.

Authors:  F Dharmasena; H Englert; D Catovsky; D A Galton; H C Drysdale
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

5.  Reactive arthritis.

Authors: 
Journal:  Br Med J       Date:  1980-05-17

6.  Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones.

Authors:  A B Hassell; D J Reynolds; M Deacon; J S Gaston; J H Pearce
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

7.  Immunochemical analysis of immune response to Chlamydia trachomatis in Reiter's syndrome and nonspecific urethritis.

Authors:  R D Inman; M E Johnston; B Chiu; J Falk; M Petric
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

8.  Campylobacter jejuni enteritis and reactive arthritis.

Authors:  C D Short; P T Klouda; L Smith
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

9.  Reactive arthritis with eosinophilic synovial infiltration.

Authors:  B Bissonnette; F Beaudet
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

10.  Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever.

Authors:  J M Valtonen; S Koskimies; A Miettinen; V V Valtonen
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.